Picture of EQTEC logo

EQT EQTEC News Story

0.000.00%
gb flag iconLast trade - 00:00
EnergyHighly SpeculativeMicro CapValue Trap

REG - EQTEC PLC - Final Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230505:nRSE4892Ya&default-theme=true

RNS Number : 4892Y  EQTEC PLC  05 May 2023

5 May 2023

 

EQTEC plc

("EQTEC", the "Company" or the "Group")

 

Audited results for the year ended 31 December 2022

 

EQTEC plc (AIM: EQT), a global technology innovator powering distributed,
decarbonised, new energy infrastructure through its waste-to-value solutions
for hydrogen, biofuels and energy generation announces its audited results for
the year ended 31 December 2022, with post-period progress.

 

Financial highlights

 

·     Revenue and other operating income: €8.0 million (2021: €9.2
million)

·     EBITDA loss before significant and non-recurring items: €4.9
million (2021: €3.8 million)

·     Net assets: €37.1 million (31 December 2021: €43.4 million)

·     Capital raise of £3.7 million (€4.2 million) through the placing
of new shares

·     Two loan facilities secured: one for up to £10 million (€11.3
million) and the other for £2 million (€2.3 million)

 

The net loss including significant and non-recurring items was €10.5 million
(2021: €4.7 million), which included an investment impairment of €4.7
million in relation to the North Fork project in California.

 

Commercial and operational highlights

 

·     Strong progress with Market Development Centres ("MDCs"):

·   Italy MDC construction completed, and commissioning commenced.

·   Croatia MDC funding identified for final construction and
recommissioning.

·   France MDC acquired, and project buyer identified for sale of the
project.

·     EQTEC France launched as wholly owned subsidiary, with strong
pipeline of projects particularly focused on renewable natural gas ("RNG") and
advanced biofuels.

·     Contaminated plastics added to EQTEC feedstock library after
testing success, followed by collaboration agreement with French waste
management company toward future plants.

·     EQTEC R&D facility at Université de Lorraine ("UL") upgraded
to support steam-oxygen gasification capabilities for testing of advanced
biofuel solutions.

·     Deeside project (UK) completed initial FEED, Livadia project
(Greece) achieved 80% funding.

·     North Fork project (USA) refinanced, and construction restarted;
Southport and Billingham projects (UK) restructured to reduce EQTEC
liabilities whilst maintaining rights to development fees due.

 

David Palumbo, CEO of EQTEC, commented:

 

"EQTEC in 2022 reaffirmed its business strategy, strengthened its growth
platform and toughened its resolve.  Based on having one of the few
technologies of its kind with a proven track record, we focused our energies
on ensuring we can truly make our technology available, reliably and
consistently, for the several business models we support in the world of new
energy infrastructure.

 

We delivered focused, formative progress in three key areas of our business
strategy. First, we pushed ahead with three MDCs, as demonstration of EQTEC's
versatile syngas solutions in live, reference plants that deliver attractive
returns through a variety of business models.  Second, we took further steps
in retaining our technology leadership, deploying upgraded R&D capability
for regular testing of solutions for advanced biofuels such as RNG, hydrogen,
liquid fuels such as sustainable aviation fuel (SAF) and for chemicals such as
ethanol or methanol.  Third, we released the Company from untenable
liabilities in major projects and turned our attention to the Tier 1 and 2
leaders that will help us deploy our solutions through the world's best
funded, best managed projects.

 

Our target remains making EQTEC a leading licensor and innovator of technology
that delivers clean, baseload energy and biofuels solutions to the world's
leading Industrial and Utility companies and to Municipalities and
Agroindustry around the globe. To become that, we must be more than simply the
leading innovator for waste-to-value solutions; we must also be known for
deploying our technology through projects that consistently deliver on time,
to budget and for plants that deliver healthy returns on investment,
sustainably over their lifetimes."

 

Current trading and outlook

 

·     France and Italy leading execution of EQTEC business strategy,
combining advanced capabilities, demonstration of EQTEC technology and
collaboration with top-tier partners:

·   Mechanical and electrical completion of Italy MDC in 2022, followed by
achievement of full operations in March 2023 with handover to the operating
company expected imminently.

·   Visits by prospective customers throughout 2022 and early 2023 to
Movialsa plant in Spain and now also to Italy MDC in Tuscany, with a full
slate of visits planned to Italy MDC in 2023.

·   Acquisition of France MDC in July 2022, followed by engagement of
prospective buyer, confirmation of planning, feedstock and offtake
arrangements; project sale expected in H1 2023.

·   Launch into the contaminated plastic waste treatment business in France
with French partner SEPS in March 2022, following completion of successful
contaminated plastic waste trials.

·   Following a competitive tender win, EQTEC and French utility partner
Idex awarded in March 2023 a waste-to-RNG project built on demonstrated
R&D capabilities.

·   Collaboration agreement in April 2023 between EQTEC and Poseidon LNG
Hub, a sister company of Belleli Group and consortium including Linde, Wood,
Alfa Laval and Chemprod.

·   Built on collaboration agreement with major players, pipeline in Italy
for at least four waste-to-RNG and waste-to-hydrogen solutions, also building
on global partnership with Wood.

 

·     Major UK, France and Ireland projects demonstrate EQTEC scale
capability with target business models and top-tier customers:

·   Reconfiguration of near-premise Industrial business model at Deeside,
Flintshire, UK for a more cost-effective, dual-technology facility deploying
Anaergia, Inc. anaerobic digestion technology and EQTEC syngas technology for
power offtake by neighbouring Toyota Motor Company engine production plant;
initial FEED completed by global EPC Black & Veatch.

·   Updated financial modelling and development strategy for Billingham
project, for an advanced facility that can support surrounding, large-scale
Industrial offtakers in Teesside, with Petrofac appointed as the FEED partner
and prospective EPC; engagement with neighbouring CF Fertilisers and other
local players for purchase of advanced biofuels.

·   Progress toward acquisition of project at decommissioned, large-scale
coal-fired power station at Gardanne, France, secured in Q1 2023; EQTEC
leading feasibility work for an early-stage design of a clean, syngas-based
production of RNG or other, advanced biofuels in support of Industrial and/or
Municipal offtake customers.

·   Engagement underway toward Ireland-based projects in support of power,
RNG or ethanol production to support Ireland's IT services industry,
de-carbonise the national grid and create autonomous, sustainable alternatives
to traditional energy solutions.

·   Appointed top-tier investment bank to approach large corporates in the
growing market for large-scale, new energy infrastructure such as RNG,
hydrogen and liquid fuels with a mandate to identify strategic investors at
individual project, project portfolio and/or Group levels.

 

·     Continued commitment to innovation and applied R&D:

·   Expansion of variable feedstock capabilities, including successful
tests of plastics and polymers contaminated with fossil fuels and other
chemicals that cannot be burned or put into landfill, and successful testing
of high-humidity RDF (refuse-derived fuel).

·   Expansion of R&D capabilities for advanced offtake applications
such as RNG, hydrogen, liquid biofuels, ethanol, methanol and other chemicals,
through upgrade of R&D facility at the University of Lorraine to
accommodate steam-oxygen gasification technology.

·   Active engagement of Wood VESTA technology for hydrogen or for RNG at
multiple project opportunities, starting with Southport project in UK, with
other opportunities in France, Italy.

·   Collaboration agreement with CompactGTL for development of liquid
biofuels through EQTEC syngas technology and CompactGTL gas-to-liquids
technology, at UK pilot plant.

·   Ireland project opportunity for development of integrated
syngas-to-ethanol capability with new technology partner to be announced.

 

·     Focus Plan in response to tighter market conditions, for
prioritised, strategic execution:

·   Portfolio prioritisation with focus on completion and live operation of
MDCs in Italy, Croatia and France, followed by development of scale
capabilities at large facilities in UK, France and Italy.

·   Exited liabilities of €18 million+ through renegotiation of
agreements at all three UK projects:  Deeside, Billingham, Southport.

·   Focus on core capabilities, bringing on top-tier development, project
management, FEED and EPC partners to support EQTEC's design, engineering and
technology integration.

 

Annual report

 

The full, 2022 annual report, which addresses all the points above and which
details full, financial results and other performance outcomes for the
Company, may be found on the Company's website at
https://eqtec.com/investing-in-eqtec/ (https://eqtec.com/investing-in-eqtec/)

 

Additionally, the full2022 annual report for the Company is available at the
following hyperlink:

http://www.rns-pdf.londonstockexchange.com/rns/4892Y_1-2023-5-4.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4892Y_1-2023-5-4.pdf)

 

The principal financial tables, extracted from the Annual Report, are set out
below:

 

 

Consolidated statement of profit or loss for the financial year ended 31
December 2022

 

                                                            Notes  2022                             2021
                                                                   €                                €
 Revenue                                                    8      7,970,072                        9,171,764
 Cost of sales                                                     (7,002,314)                      (7,541,354)
 Gross profit                                                      967,758                          1,630,410
 Operating income/(expenses)
 Administrative expenses                                           (5,742,563)                      (4,190,592)
 Other income                                               9      33,645                           -
 Impairment costs                                           14     (2,752)                          (5,498)
 Other (gains)/losses                                       12     10,088                           (1,418,860)
 Employee share-based compensation                          10     (340,257)                        (205,648)
 Foreign currency gains                                            156,835                          348,885
 Operating loss                                                    (4,917,246)                      (3,841,303)
 Share of results from equity accounted investments         21     (52,059)                         (24,188)
 Gains from sales to equity accounted investments deferred  21     (28,378)                         (211,478)
 Loss/(gain) arising from loss of control of subsidiaries          (489)                            9,957
 Change in fair value of financial investments                     (326,501)                        (250,378)

                                                            23
 Finance income                                             11     316,805                          134,069
 Finance costs                                              11     (589,618)                        (517,108)
 Significant and non-recurring transactions:
 Impairment of equity-accounted investment                  15     (4,712,490)                      -
 Loss on disposal of tangible asset                         15     (154,205)                                            -
 Loss before taxation                                       14     (10,464,181)                     (4,700,429)
 Income tax                                                 16     (60,934)                                            -

 LOSS FOR THE FINANCIAL YEAR                                       (10,525,115)                     (4,700,429)
 Loss attributable to:
 Owners of the Company                                             (10,525,104)                     (4,700,497)
 Non-controlling interest                                                        (11)                               68

                                                                   (10,525,115)                     (4,700,429)

                                                                   2022                             2021
                                                                   € per share                      € per share
 Basic loss per share:
 From continuing operations                                 17     (0.001)                          (0.001)
 From continuing and discontinued operations                17     (0.001)                          (0.001)
 Diluted loss per share:
 From continuing operations                                 17     (0.001)                          (0.001)
 From continuing and discontinued operations                17     (0.001)                          (0.001)

 

 

Consolidated statement of comprehensive income for the financial year ended 31
December 2022

 

                                                    2022          2021
                                                    €             €

 Loss for the financial year                        (10,525,115)  (4,700,429)

 Other comprehensive (loss)/income

 Items that may be reclassified

 subsequently to profit or loss
 Exchange differences arising on re-translation
 of foreign operations                              (478,066)     238,715

 Other comprehensive (loss)/income for the year     (478,066)     238,715

 Total comprehensive loss for the financial year    (11,003,181)  (4,461,714)

 Attributable to:
 Owners of the company                              (11,128,847)  (4,301,511)
 Non-controlling interests                          125,666       (160,203)

                                                    (11,003,181)  (4,461,714)

 

 

Consolidated statement of financial position at 31 December 2022

 

                                                        Notes  2022                            2021
 ASSETS                                                        €                               €
 Non-current assets
 Property, plant and equipment                          18     133,053                         446,861
 Intangible assets                                      19     17,578,231                      17,702,833
 Investments accounted for using the equity method      21     7,619,514                       8,074,184
 Financial assets                                       22     3,728,434                       4,050,030
 Other financial investments                            23           171,186                   506,976

 Total non-current assets                                      29,230,418                      30,780,884

 Current assets
 Development assets                                     25     6,033,543                       3,455,496
 Loan receivable from project development undertakings  25     5,446,087                       3,000,469
 Trade and other receivables                            26     7,221,046                       6,876,747
 Cash and cash equivalents                              27     1,693,116                       6,446,217

 Total current assets                                          20,393,792                      19,778,929

 Total assets                                                  49,624,210                      50,559,813

 EQUITY AND LIABILITIES                                        €                               €
 Equity
 Share capital                                          28     26,799,584                      25,977,130
 Share premium                                          28     87,203,372                      83,610,562
 Other reserves                                         28     2,694,125                       2,353,868
 Accumulated deficit                                           (77,305,919)                    (66,177,072)

 Equity attributable to the owners of the company              39,391,162                      45,764,488
 Non-controlling interests                              29     (2,258,523)                     (2,384,189)

 Total equity                                                  37,132,639                      43,380,299

 Non-current liabilities
 Borrowings                                             30     1,064,598                       -
 Lease liabilities                                      31                    -                56,855

 Total non-current liabilities                                 1,064,598                       56,855

 Current liabilities
 Trade and other payables                               32     6,264,404                       6,921,806
 Borrowings                                             30     5,106,038                       -
 Lease liabilities                                      31             56,531                  200,853

 Total current liabilities                                     11,426,973                      7,122,659

 Total equity and liabilities                                  49,624,210                      50,559,813

 

The financial statements were approved by the Board of Directors on 5 May 2023
and signed on its behalf by:

 

 

Ian Pearson
 
        David Palumbo

Non-Executive
Chairman
Chief Executive Officer

05 May 2023
 
        05 May 2023

 

 

 

Consolidated statement of changes in equity for the financial year ended 31
December 2022

 

                                                     Share                                                                             Other reserves                    Accumulated deficit                     Equity attributable to owners of the company  Non-controlling interests

                                                     Capital                                 Share premium                                                                                                                                                                                             Total
                                                     €                                       €                                         €                                 €                                       €                                             €                                       €
 Balance at 1 January 2021                           24,355,545                              62,896,521                                2,148,220                         (61,875,561)                            27,524,725                                    (2,223,986)                             25,300,739
 Issue of ordinary shares in EQTEC plc (Note 28)     1,402.324                               18,206,268                                -                                 -                                       19,608,592                                    -                                       19,608,592
 Conversion of debt into equity (Notes 28)           167,728                                 3,285,013                                 -                                 -                                       3,452,741                                     -                                       3,452,741
 Issued in acquisition of financial asset (Note 28)  51,533                                  693,628                                   -                                 -                                       745,161                                       -                                       745,161
 Share issue costs (Note 28)                         -                                       (1,470,868)                               -                                 -                                       (1,470,868)                                   -                                       (1,470,868)
 Employee share-based compensation (Notes 10)                           -                                       -                         205,648                                           -                    205,648                                                        -                      205,648
 Transactions with owners                              1,621,585                             20,714,041                                   205,648                                           -                    22,541,274                                                      -                     22,541,274
 Loss for the financial year                         -                                       -                                         -                                 (4,700,497)                             (4,700,497)                                   68                                      (4,700,429)
 Unrealised foreign exchange losses                                    -                                       -                                       -                      398,986                                 398,986                                  (160,271)                                     238,715
 Total comprehensive loss for the financial year                        -                                      -                                       -                 (4,301,511)                             (4,301,511)                                   (160,203)                               (4,461,714)
 Balance at 31 December 2021                         25,977,130                              83,610,562                                2,353,868                         (66,177,072)                            45,764,488                                    (2,384,189)                             43,380,299
 Issue of ordinary shares in EQTEC plc (Note 28)     769,697                                 3,717,379                                 -                                 -                                       4,487,076                                     -                                       4,487,076
 Conversion of debt into equity (Note 28)            52,757                                  237,672                                   -                                 -                                       290,429                                       -                                       290,429
 Share issue costs (Note 28)                         -                                       (362,241)                                 -                                 -                                       (362,241)                                     -                                       (362,241)
 Employee share-based compensation (Note 10)                            -                                      -                       340,257                                             -                     340,257                                                         -                     340,257
 Transactions with owners                                 822,454                            3,592,810                                 340,257                                              -                    4,755,521                                                        -                    4,755,521
 Loss for the financial year                         -                                       -                                         -                                 (10,525,104)                            (10,525,104)                                  (11)                                    (10,525,115)
 Unrealised foreign exchange losses                                    -                                         -                                     -                      (603,743)                               (603,743)                                    125,677                             (478,066)
 Total comprehensive loss for the financial year                       -                                        -                                      -                 (11,128,847)                            (11,128,847)                                        125,666                           (11,003,181)
 Balance at 31 December 2022                         26,799,584                              87,203,372                                2,694,125                         (77,305,919)                            39,391,162                                    (2,258,523)                             37,132,639

 

 

Consolidated statement of cash flows for the financial year ended 31 December
2022

 

                                                                   Notes  2022          2021
                                                                          €             €
 Cash flows from operating activities
 Loss for the financial year before income tax                            (10,464,181)  (4,700,429)
 Adjustments for:
 Depreciation of property, plant and equipment                     18     239,233       156,520
 Amortisation of intangible assets                                 19     124,602       72,685
 Loss on disposal of tangible assets                               15     154,205       -
 Impairment of equity-accounted investments                        15     4,712,490     -
 Employee share-based compensation                                 10     340,257       205,648
 Impairment of development assets                                  25     2,752         -
 Share of loss of equity accounted investments                     21     52,059        24,188
 Gains from sales to equity accounted investments deferred         21     28,378        211,478
 Loss/(gain) on loss of control of subsidiary                      20     489           (9,957)
 Change in fair value of financial investments                     23     326,501       250,378
 (Gain)/loss on debt for equity swap                               12     (10,088)      1,418,860
 Unrealised foreign exchange movements                                    (319,440)     103,234
 Operating cash flows before working capital changes                      (4,812,743)   (2,267,395)
 Increase in:
 Development assets                                                       (2,578,047)   (3,144,600)
 Trade and other receivables                                              (2,837,708)   (5,946,010)
 (Decrease)/increase in Trade and other payables                          (274,938)     3,432,256
 Net cash used in operating activities - continuing operations            (10,503,436)  (7,925,749)
 Finance income                                                    11     (316,805)     (134,069)
 Finance costs                                                     11     589,618       517,108
 Taxes paid                                                               (108,311)                         -

 Net cash used in operating activities                                    (10,338,934)  (7,542,710)

 Cash flows from investing activities
 Addition to tangible assets                                       18     (79,199)      -
 Additions to intangible assets                                    19     -             (1,000,000)
 Payments on deposit on land                                       26     (586,421)     -
 Cash inflow from disposal of subsidiary                           33     170,000       -
 Loans advanced to project development undertakings                25     (773,034)     (2,430,137)
 Loans repaid by project development undertakings                  25     100,000       -
 Investment in equity accounted undertakings                       21     (6,790)       (978,825)
 Loans advanced to equity accounted undertakings                   21     (2,852,699)   (3,746,984)
 Loans repaid by equity accounted undertakings                     21     40,018        -
 Investment in related undertakings                                22     (351,853)     (697,635)
 Other advances to equity accounted undertakings

                                                                          (2,000)       (27,508)

 Net cash used in investing activities                                    (4,341,978)   (8,881,089)

 Cash flows from financing activities
 Proceeds from borrowings and lease liabilities                    30     7,236,850     1,391,174
 Repayment of borrowings and lease liabilities                     30     (1,126,483)   (3,031,724)
 Loan issue costs                                                  30     (334,557)     -
 Proceeds from issue of ordinary shares                            28     4,430,069     19,420,222
 Share issue costs                                                 28     (274,784)     (1,180,217)
 Interest paid                                                            (3,284)                     (20)

 Net cash generated from financing activities                             9,927,811     16,599,435

 Net (decrease)/increase in cash and cash equivalents                     (4,753,101)   175,636

 Cash and cash equivalents at the beginning of the financial year         6,446,217     6,270,581

 Cash and cash equivalents at the end of the financial year        27     1,693,116     6,446,217

 

 

ENQUIRIES

 

 EQTEC plc                                              +44 20 3883 7009

 David Palumbo / Nauman Babar


 Strand Hanson - Nomad & Financial Adviser              +44 20 7409 3494

 James Harris / Richard Johnson

 Panmure Gordon - Broker                                +44 20 7886 2500

 John Prior / Hugh Rich

 Instinctif - Media & investor relations enquiries      EQTEC@instinctif.com (mailto:EQTEC@instinctif.com)

 Guy Scarborough / Tim Field                            +44 791 717 8920 / +44 788 788 4794

 

About EQTEC plc

 

As one of the world's most experienced gasification technology and engineering
companies, with a growing track record of delivering operational and
commercial success for transforming waste-to-energy through best-in-class
technology innovation, engineering and project development, EQTEC brings
together design innovation, project delivery discipline and solid commercial
experience to add momentum to the global energy transition. EQTEC's proven,
proprietary and patented technology is at the centre of clean energy
projects, sourcing local waste, championing local businesses, creating local
jobs and supporting the transition to localised, decentralised and resilient
energy systems.

 

EQTEC designs, supplies and builds advanced gasification facilities in the UK,
EU and US, with highly efficient equipment that is modular and scalable from
1MW to 30MW. EQTEC's versatile solutions process over 50 varieties of
feedstock, including forestry wood waste, vegetation and other agricultural
waste from farmers, industrial waste and sludge from factories and municipal
waste, all with no hazardous or toxic emissions. EQTEC's solutions produce a
pure, high-quality synthesis gas ("syngas") that can be used for the widest
range of applications, including the generation of electricity and heat,
production of synthetic natural gas (through methanation) or biofuels (through
Fischer-Tropsch, gas-to-liquid processing) and reforming of hydrogen.

 

EQTEC's technology integration capabilities enable the Group to lead
collaborative ecosystems of qualified partners and to build sustainable waste
reduction and green energy infrastructure around the world.

 

The Company is quoted on AIM (ticker: EQT) and the London Stock Exchange has
awarded EQTEC the Green Economy Mark, which recognises listed companies with
50% or more of revenues from environmental/green solutions.

 

Further information on the Company can be found at www.eqtec.com
(http://www.eqtec.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR NKQBBABKDAPK

Recent news on EQTEC

See all news